Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions

Journal of General Virology

Volumn 93, Issue PART 9, 2012, Pages 1876-1886

  Doceul, Virginie ^a,b   Hollinshead, Michael ^a   Breiman, Adrien ^a,c   Laval, Kathlyn ^a,d   Smith, Geoffrey L ^a,e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d GHENT UNIVERSITY   (Belgium)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN A33; PROTEIN A36; PROTEIN B5; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACTIN POLYMERIZATION; ARTICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINIA VIRUS; VIRION; VIRUS ENVELOPE; VIRUS PLAQUE; VIRUS REPLICATION;

ACTINS; CELL MEMBRANE; HELA CELLS; HUMANS; SUPERINFECTION; VACCINIA; VACCINIA VIRUS; VIRAL MATRIX PROTEINS; VIRAL PLAQUE ASSAY; VIRION; VIRUS INTERNALIZATION;

EID: 84865119394     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.043943-0     Document Type: Article

References (83)

1. Alcamí, A. & Smith, G. L. (1992). A soluble receptor for interleukin-1b encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71, 153-167.
2. Blasco, R. & Moss, B. (1991). Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-dalton outer envelope protein. J Virol 65, 5910-5920.
3. Blasco, R., Sisler, J. R. & Moss, B. (1993). Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene. J Virol 67, 3319-3325.
4. Breiman, A. & Smith, G. L. (2010). Vaccinia virus B5 protein affects the glycosylation, localization and stability of the A34 protein. J Gen Virol 91, 1823-1827.
5. Condit, R. C., Moussatche, N. & Traktman, P. (2006). In a nutshell: structure and assembly of the vaccinia virion. Adv Virus Res 66, 31-124.
6. Cudmore, S., Cossart, P., Griffiths, G. & Way, M. (1995). Actin-based motility of vaccinia virus. Nature 378, 636-638.
7. DeHaven, B. C., Girgis, N. M., Xiao, Y., Hudson, P. N., Olson, V. A., Damon, I. K. & Isaacs, S. N. (2010). Poxvirus complement control proteins are expressed on the cell surface through an intermolecular disulfide bridge with the viral A56 protein. J Virol 84, 11245-11254.
8. DeHaven, B. C., Gupta, K. & Isaacs, S. N. (2011). The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins. J Gen Virol 92, 1971-1980.
9. Demaison, C., Parsley, K., Brouns, G., Scherr, M., Battmer, K., Kinnon, C., Grez, M. & Thrasher, A. J. (2002). High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 13, 803-813.
10. Doceul, V., Hollinshead, M., van der Linden, L. & Smith, G. L. (2010). Repulsion of superinfecting virions: a mechanism for rapid virus spread. Science 327, 873-876.
11. Drexler, I., Heller, K., Wahren, B., Erfle, V. & Sutter, G. (1998). Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells. J Gen Virol 79, 347-352.
12. Duncan, S. A. & Smith, G. L. (1992). Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. J Virol 66, 1610-1621.
13. Earley, A. K., Chan, W. M. & Ward, B. M. (2008). The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions. J Virol 82, 2161-2169.
14. Engelstad, M. & Smith, G. L. (1993). The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 194, 627-637.
15. Engelstad, M., Howard, S. T. & Smith, G. L. (1992). A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188, 801-810.
16. Fogg, C., Lustig, S., Whitbeck, J. C., Eisenberg, R. J., Cohen, G. H. & Moss, B. (2004). Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions. J Virol 78, 10230-10237.
17. Frischknecht, F., Moreau, V., Röttger, S., Gonfloni, S., Reckmann, I., Superti-Furga, G. & Way, M. (1999). Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 401, 926-929.
18. Galmiche, M. C., Goenaga, J., Wittek, R. & Rindisbacher, L. (1999). Neutralizing and protective antibodies directed against vaccinia virus envelope antigens. Virology 254, 71-80.
19. Geada, M. M., Galindo, I., Lorenzo, M. M., Perdiguero, B. & Blasco, R. (2001). Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein. J Gen Virol 82, 2747-2760.
20. Grosenbach, D. W., Hansen, S. G. & Hruby, D. E. (2000). Identification and analysis of vaccinia virus palmitylproteins. Virology 275, 193-206.
21. Herrera, E., Lorenzo, M. M., Blasco, R. & Isaacs, S. N. (1998). Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain. J Virol 72, 294-302.
22. Herrero-Martínez, E., Roberts, K. L., Hollinshead, M. & Smith, G. L. (2005). Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein. J Gen Virol 86, 2961-2968.
23. Hiller, G., Weber, K., Schneider, L., Parajsz, C. & Jungwirth, C. (1979). Interaction of assembled progeny pox viruses with the cellular cytoskeleton. Virology 98, 142-153.
24. Hollinshead, M., Vanderplasschen, A., Smith, G. L. & Vaux, D. J. (1999). Vaccinia virus intracellular mature virions contain only one lipid membrane. J Virol 73, 1503-1517.
25. Hollinshead, M., Rodger, G., Van Eijl, H., Law, M., Hollinshead, R., Vaux, D. J. & Smith, G. L. (2001). Vaccinia virus utilizes microtubules for movement to the cell surface. J Cell Biol 154, 389-402.
26. Hughes, S. J., Johnston, L. H., de Carlos, A. & Smith, G. L. (1991). Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae. J Biol Chem 266, 20103-20109.
27. Husain, M., Weisberg, A. & Moss, B. (2003). Topology of epitopetagged F13L protein, a major membrane component of extracellular vaccinia virions. Virology 308, 233-242.
28. Isaacs, S. N., Wolffe, E. J., Payne, L. G. & Moss, B. (1992). Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. J Virol 66, 7217-7224.
29. Katz, E., Wolffe, E. & Moss, B. (2002). Identification of second-site mutations that enhance release and spread of vaccinia virus. J Virol 76, 11637-11644.
30. Katz, E., Ward, B. M., Weisberg, A. S. & Moss, B. (2003). Mutations in the vaccinia virus A33R and B5R envelope proteins that enhancerelease of extracellular virions and eliminate formation of actincontaining microvilli without preventing tyrosine phosphorylation of the A36R protein. J Virol 77, 12266-12275.
31. Kerr, S. M., Johnston, L. H., Odell, M., Duncan, S. A., Law, K. M. & Smith, G. L. (1991). Vaccinia DNA ligase complements Saccharomyces cerevisiae cdc9, localizes in cytoplasmic factories and affects virulence and virus sensitivity to DNA damaging agents. EMBO J 10, 4343-4350.
32. Law, K. M. & Smith, G. L. (1992). A vaccinia serine protease inhibitor which prevents virus-induced cell fusion. J Gen Virol 73, 549-557.
33. Law, M. & Smith, G. L. (2001). Antibody neutralization of the extracellular enveloped form of vaccinia virus. Virology 280, 132-142.
34. Law, M., Hollinshead, R. & Smith, G. L. (2002). Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread. J Gen Virol 83, 209-222.
35. Law, M., Carter, G. C., Roberts, K. L., Hollinshead, M. & Smith, G. L. (2006). Ligand-induced and nonfusogenic dissolution of a viral membrane. Proc Natl Acad Sci U S A 103, 5989-5994.
36. Lorenzo, M. M., Herrera, E., Blasco, R. & Isaacs, S. N. (1998). Functional analysis of vaccinia virus B5R protein: role of the cytoplasmic tail. Virology 252, 450-457.
37. Lorenzo, M. M., Galindo, I., Griffiths, G. & Blasco, R. (2000). Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon. J Virol 74, 10535-10550.
38. Lorenzo, M. M., Sánchez-Puig, J. M. & Blasco, R. (2012). Mutagenesis of the palmitoylation site in vaccinia virus envelope glycoprotein B5. J Gen Virol 93, 733-743.
39. Mackett, M., Smith, G. L. & Moss, B. (1984). General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol 49, 857-864.
40. Mathew, E., Sanderson, C. M., Hollinshead, M. & Smith, G. L. (1998). The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation. J Virol 72, 2429-2438.
41. Mathew, E. C., Sanderson, C. M., Hollinshead, R., Hollinshead, M., Grimley, R. & Smith, G. L. (1999). The effects of targeting the vaccinia virus B5R protein to the endoplasmic reticulum on virus morphogenesis and dissemination. Virology 265, 131-146.
42. Mathew, E. C., Sanderson, C. M., Hollinshead, R. & Smith, G. L. (2001). A mutational analysis of the vaccinia virus B5R protein. J Gen Virol 82, 1199-1213.
43. McIntosh, A. A. & Smith, G. L. (1996). Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J Virol 70, 272-281.
44. Moss, B. (2007). Poxviridae: the viruses and their replicaton. In Fields Virology, 5th edn, pp. 2905-2946.
45. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
46. Newsome, T. P., Scaplehorn, N. & Way, M. (2004). SRC mediates a switch from microtubule- to actin-based motility of vaccinia virus. Science 306, 124-129.
47. Okeke, M. I., Nilssen, O. & Traavik, T. (2006). Modified vaccinia virus Ankara multiplies in rat IEC-6 cells and limited production of mature virions occurs in other mammalian cell lines. J Gen Virol 87, 21-27.
48. Parkinson, J. E. & Smith, G. L. (1994). Vaccinia virus gene A36R encodes a Mr 43-50 K protein on the surface of extracellular enveloped virus. Virology 204, 376-390.
49. Payne, L. G. (1979). Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus. J Virol 31, 147-155.
50. Payne, L. G. & Kristenson, K. (1979). Mechanism of vaccinia virus release and its specific inhibition by N1-isonicotinoyl-N2-3-methyl-4- chlorobenzoylhydrazine. J Virol 32, 614-622.
51. Payne, L. G. & Norrby, E. (1976). Presence of haemagglutinin in the envelope of extracellular vaccinia virus particles. J Gen Virol 32, 63-72.
52. Perdiguero, B. & Blasco, R. (2006). Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins. J Virol 80, 8763-8777.
53. Perdiguero, B., Lorenzo, M. M. & Blasco, R. (2008). Vaccinia virus A34 glycoprotein determines the protein composition of the extracellular virus envelope. J Virol 82, 2150-2160.
54. Rietdorf, J., Ploubidou, A., Reckmann, I., Holmström, A., Frischknecht, F., Zettl, M., Zimmermann, T. & Way, M. (2001). Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus. Nat Cell Biol 3, 992-1000.
55. Roberts, K. L., Breiman, A., Carter, G. C., Ewles, H. A., Hollinshead, M., Law, M. & Smith, G. L. (2009). Acidic residues in the membraneproximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane. J Gen Virol 90, 1582-1591.
56. Roper, R. L., Payne, L. G. & Moss, B. (1996). Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J Virol 70, 3753-3762.
57. Roper, R. L., Wolffe, E. J., Weisberg, A. & Moss, B. (1998). The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J Virol 72, 4192-4204.
58. Röttger, S., Frischknecht, F., Reckmann, I., Smith, G. L. & Way, M. (1999). Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. J Virol 73, 2863-2875.
59. Sanderson, C. M., Frischknecht, F., Way, M., Hollinshead, M. & Smith, G. L. (1998a). Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion. J Gen Virol 79, 1415-1425.
60. Sanderson, C. M., Way, M. & Smith, G. L. (1998b). Virus-induced cell motility. J Virol 72, 1235-1243.
61. Scaplehorn, N., Holmström, A., Moreau, V., Frischknecht, F., Reckmann, I. & Way, M. (2002). Grb2 and Nck act cooperatively to promote actin-based motility of vaccinia virus. Curr Biol 12, 740-745.
62. Schmelz, M., Sodeik, B., Ericsson, M., Wolffe, E. J., Shida, H., Hiller, G. & Griffiths, G. (1994). Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol 68, 130-147.
63. Schmidt, F. I., Bleck, C. K., Helenius, A. & Mercer, J. (2011). Vaccinia extracellular virions enter cells by macropinocytosis and acidactivated membrane rupture. EMBO J 30, 3647-3661.
64. Smith, G. L., Mackett, M. & Moss, B. (1983). Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 302, 490-495.
65. Smith, G. L., Vanderplasschen, A. & Law, M. (2002). The formation and function of extracellular enveloped vaccinia virus. J Gen Virol 83, 2915-2931.
66. Smith, G. L., Murphy, B. J. & Law, M. (2003). Vaccinia virus motility. Annu Rev Microbiol 57, 323-342.
67. Stokes, G. V. (1976). High-voltage electron microscope study of the release of vaccinia virus from whole cells. J Virol 18, 636-643.
68. Su, H. P., Singh, K., Gittis, A. G. & Garboczi, D. N. (2010). The structure of the poxvirus A33 protein reveals a dimer of unique Ctype lectin-like domains. J Virol 84, 2502-2510.
69. Takahashi-Nishimaki, F., Funahashi, S., Miki, K., Hashizume, S. & Sugimoto, M. (1991). Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins. Virology 181, 158-164.
70. Turner, P. C. & Moyer, R. W. (2006). The cowpox virus fusion regulator proteins SPI-3 and hemagglutinin interact in infected and uninfected cells. Virology 347, 88-99.
71. Valderrama, F., Cordeiro, J. V., Schleich, S., Frischknecht, F. & Way, M. (2006). Vaccinia virus-induced cell motility requires F11Lmediated inhibition of RhoA signaling. Science 311, 377-381.
72. van Eijl, H., Hollinshead, M. & Smith, G. L. (2000). The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. Virology 271, 26-36.
73. van Eijl, H., Hollinshead, M., Rodger, G., Zhang, W. H. & Smith, G. L. (2002). The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J Gen Virol 83, 195-207.
74. Wagenaar, T. R. & Moss, B. (2007). Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex. J Virol 81, 6286-6293.
75. Wagenaar, T. R. & Moss, B. (2009). Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion. J Virol 83, 1546-1554.
76. Wagenaar, T. R., Ojeda, S. & Moss, B. (2008). Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex. J Virol 82, 5153-5160.
77. Ward, B. M. & Moss, B. (2001). Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails. J Virol 75, 11651-11663.
78. Ward, B. M., Weisberg, A. S. & Moss, B. (2003). Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins. J Virol 77, 4113-4126.
79. Wolffe, E. J., Isaacs, S. N. & Moss, B. (1993). Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J Virol 67, 4732-4741.
80. Wolffe, E. J., Weisberg, A. S. & Moss, B. (2001). The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein. J Virol 75, 303-310.
81. Zhang, W. H., Wilcock, D. & Smith, G. L. (2000). Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence. J Virol 74, 11654-11662.
82. Zhou, J., Sun, X. Y., Fernando, G. J. & Frazer, I. H. (1992). The vaccinia virus K2L gene encodes a serine protease inhibitor which inhibits cell-cell fusion. Virology 189, 678-686.
83. Zwilling, J., Sliva, K., Schwantes, A., Schnierle, B. & Sutter, G. (2010). Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells. Virology 404, 231-239.